問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2009-06-01 - 2012-12-31
Condition/Disease
Test Drug
Participate Sites5Sites
Terminated5Sites
2018-07-31 - 2020-01-31
Overactive Bladder
Uritos
Participate Sites12Sites
Terminated11Sites
2008-04-01 - 2008-10-31
2014-10-01 - 2024-12-30
PROSTATE CANCER
MCS®
Participate Sites21Sites
Recruiting6Sites
Study ended15Sites
2009-12-01 - 2013-12-31
Terminated12Sites
2012-09-01 - 2015-12-31
Participate Sites6Sites
Study ended6Sites
2019-02-01 - 2019-12-25
Recruiting5Sites
2018-09-01 - 2022-12-31
Hepatocellular Carcinoma (HCC)
nivolumab﹝Opdivo﹞/ ipilimumab ﹝Yervoy﹞
Participate Sites9Sites
Recruiting8Sites
2019-04-01 - 2025-12-31
Alzheimer’s disease
F-18 AV-45
Participate Sites2Sites
Recruiting2Sites
2017-11-01 - 2021-12-08
Acute primary cerebral hemorrhage
Three-dose combination(telmisartan, amlodipine, indapamide)
Participate Sites4Sites
Recruiting3Sites
Study ended1Sites
Division of Neurology
全部
